about
Urocortin II is expressed in human pregnant myometrial cells and regulates myosin light chain phosphorylation: potential role of the type-2 corticotropin-releasing hormone receptor in the control of myometrial contractilityFunctional characteristics of CRH receptors and potential clinical applications of CRH-receptor antagonistsExtra-nuclear telomerase reverse transcriptase (TERT) regulates glucose transport in skeletal muscle cellsIntracellular mechanisms regulating corticotropin-releasing hormone receptor-2beta endocytosis and interaction with extracellularly regulated kinase 1/2 and p38 mitogen-activated protein kinase signaling cascades.Up-regulation of nitric oxide synthase and modulation of the guanylate cyclase activity by corticotropin-releasing hormone but not urocortin II or urocortin III in cultured human pregnant myometrial cells.Inhibition of Akt activity and calcium channel function coordinately drive cell-cell fusion in the BeWO choriocarcinoma placental cell line.The role of corticotropin-releasing hormone receptors in placenta and fetal membranes during human pregnancy.Insights into mechanisms of corticotropin-releasing hormone receptor signal transduction.Severe paraneoplastic hypoglycemia secondary to a gastrointestinal stromal tumour masquerading as a strokeThe molecular mechanisms underlying the regulation of the biological activity of corticotropin-releasing hormone receptors: implications for physiology and pathophysiology.Hormonal regulation of placental nitric oxide and pathogenesis of pre-eclampsia.Pathological interactions with the timing of birth and uterine activation.Corticotropin-releasing hormone interacts with interleukin-1β to regulate prostaglandin H synthase-2 expression in human myometrium during pregnancy and labor.The identification of mitochondrial DNA variants in glioblastoma multiforme.Characterising the corticotropin-releasing hormone (CRH) receptors mediating CRH and urocortin actions during human pregnancy and labour.Estrogen alters the splicing of type 1 corticotropin-releasing hormone receptor in breast cancer cells.Regulation of G-protein coupled receptor signalling underpinning neurobiology of mood disorders and depression.Corticotropin-Releasing Hormone As the Homeostatic Rheostat of Feto-Maternal Symbiosis and Developmental Programming In Utero and Neonatal Life.Interplay of cAMP and MAPK pathways in hCG secretion and fusogenic gene expression in a trophoblast cell line.Structural domains determining signalling characteristics of the CRH-receptor type 1 variant R1beta and response to PKC phosphorylation.Urocortin, but not corticotropin-releasing hormone (CRH), activates the mitogen-activated protein kinase signal transduction pathway in human pregnant myometrium: an effect mediated via R1alpha and R2beta CRH receptor subtypes and stimulation of Gq-CRH-R splicing in estrogen-sensitive breast cancer.The corticotrophin-releasing factor/urocortin system regulates white fat browning in mice through paracrine mechanisms.Cyclic AMP enhances progesterone action in human myometrial cells.Potential signalling pathways underlying corticotrophin-releasing hormone-mediated neuroprotection from excitotoxicity in rat hippocampus.Protein kinase A-induced negative regulation of the corticotropin-releasing hormone R1alpha receptor-extracellularly regulated kinase signal transduction pathway: the critical role of Ser301 for signaling switch and selectivity.Expression and signalling characteristics of the corticotrophin-releasing hormone receptors during the implantation phase in the human endometrium.Preeclampsia is associated with impaired regulation of the placental nitric oxide-cyclic guanosine monophosphate pathway by corticotropin-releasing hormone (CRH) and CRH-related peptides.Glyoxalase 1 copy number variation in patients with well differentiated gastro-entero-pancreatic neuroendocrine tumours (GEP-NET).Human corticotropin-releasing hormone receptor: differences in subtype expression between pregnant and nonpregnant myometria.Metabolic phenotype of male obesity-related secondary hypogonadism pre-replacement and post-replacement therapy with intra-muscular testosterone undecanoate therapy.Authors response to Stergiakouli et al.CRH Receptor Signalling: Potential Roles in Pathophysiology.The identification of a human myometrial corticotropin-releasing hormone receptor that increases in affinity during pregnancy.Hypertestosteronemia and Infertility from a Mediastinal Extragonadal Germ Cell Tumor.Reduced expression of corticotropin-releasing hormone receptor type-1 alpha in human preeclamptic and growth-restricted placentas.The Onset of Labor Alters Corticotropin-Releasing Hormone Type 1 Receptor Variant Expression in Human Myometrium: Putative Role of Interleukin-1βImproved Thyroid Hypoechogenicity Following Bariatric-Induced Weight Loss in Euthyroid Adults With Severe Obesity-a Pilot StudyModelling of psychosocial and lifestyle predictors of peripartum depressive symptoms associated with distinct risk trajectories: a prospective cohort studyThe biological activity of the corticotropin-releasing hormone receptor-adenylate cyclase complex in human myometrium is reduced at the end of pregnancy
P50
Q28181044-6C08C743-AB8D-4462-8B71-6F42038085E5Q28214775-F28CBD53-5A2F-4F41-AA25-1884F10A51A1Q28589255-E2C1C75B-1FE4-45D4-BDD0-A3A08E5EAA94Q33643265-121870CB-236A-4CC1-B0B9-D844988548AFQ34017553-CD4628C1-F617-4312-8BFC-8AD93AB37676Q34140178-5EFF38A2-CE99-49B3-BC8C-5BB138D55C40Q34207325-8D322B37-7F95-479E-8970-1B3E88B7354EQ36153237-A18CF3BC-E9BF-4D61-8A5B-22B01D543D85Q36238550-DDA384ED-5015-447E-9659-C9383E6B3546Q36399313-62A23DF3-6138-4593-9CAD-0CB77C1A1531Q36450097-752FF902-9705-49F6-A434-BCB01D7A9428Q36996530-38FD447C-04DC-4A51-9FDD-860934EACB4EQ37424706-8BE262A1-F907-4264-8303-C0DFCD373B23Q37551852-BF5FC1C0-D7F7-4918-9F31-0E1204A11087Q37995212-3A90CF43-B37F-4EFA-ACBB-83A8F9B5FF60Q39131186-B4E37E2F-F1CB-4098-AE75-8CCC7238CDA2Q39147632-8FB2F30D-7B07-4F00-A204-C86C7A6A84EBQ39458387-19DA8966-49D1-4729-9837-5E13C4F28B0DQ39638147-40FDCF54-F525-4C1B-887F-0B757424A7A2Q40072646-FEB175DD-81A7-462D-8FE3-899B6F41A368Q40837517-64555ECB-B6CE-4FF7-806F-359B5E4D6884Q42366650-9D49D717-CAAB-4835-BE62-34242004B11BQ42796049-B85E7F9D-DDED-4375-B8F6-EA883ED76BECQ43678571-367D4008-B75A-4328-831A-9FE11EE9346BQ43927127-0FB4EA9B-93FD-4B3D-8CDA-FB883E86311EQ44681184-4A898DC2-71E9-41F6-A9A6-5F742154948AQ44757840-12483FC1-1E02-4D1F-A367-A8538FF99689Q46398451-5DAE4CF6-ABBF-4164-81D1-E527A07C9B44Q47142152-B906F00A-89DB-45E8-9A21-D6FF91068B06Q47856062-0E68E8A3-12C6-467C-A482-E6370C0B5ECBQ48041969-7D446DB1-075D-4F45-AF7D-2913856769BDQ48292764-36B4A162-D3C5-43FC-90A2-DAD7CC1543B4Q51181101-07F52505-C525-499E-90CD-0695341851D4Q52400364-26854504-63ED-40EC-8E88-E0C3134E90ADQ52795185-CD1D53FC-FC56-482D-AF97-52228629C9D8Q54796134-81AFEBE5-9DE3-445A-944C-45B0D1881E8BQ58450573-083F163A-5676-428B-A6B9-5021C2451B5DQ58705449-37D78866-829E-4489-8793-FD7D6E54715CQ58707864-8D66248C-4AA6-4330-95F2-C207BCBC7F99Q71091928-F8B8324E-FE2C-4BA5-8667-A6AA03004F20
P50
description
researcher ORCID ID = 0000-0002-6296-8290
@en
wetenschapper
@nl
name
Dimitris K Grammatopoulos
@ast
Dimitris K Grammatopoulos
@en
Dimitris K Grammatopoulos
@es
Dimitris K Grammatopoulos
@nl
type
label
Dimitris K Grammatopoulos
@ast
Dimitris K Grammatopoulos
@en
Dimitris K Grammatopoulos
@es
Dimitris K Grammatopoulos
@nl
prefLabel
Dimitris K Grammatopoulos
@ast
Dimitris K Grammatopoulos
@en
Dimitris K Grammatopoulos
@es
Dimitris K Grammatopoulos
@nl
P1153
6701796889
P21
P31
P496
0000-0002-6296-8290